ANAC

Anacor Pharmaceuticals’ CEO Discusses Q4 2013 Results – Earnings Call Transcript

[at Seeking Alpha] – David Perry Thank you, DeDe. Good afternoon everybody and thank you for joining us on the call today. I am going to break my comments into two sections, and first, highlight some Anacor’s significant achievements … moreView todays social media effects on ANACView the latest stocks trending across Twitter. Click to view dashboardSee who Anacor is […]

7:32 am Anacor Pharma announces successful completion of End-of-Phase 2 meeting with FDA for the treatment of mild-to-moderate atopic dermatitis with AN2728

moreView todays social media effects on ANACView the latest stocks trending across Twitter. Click to view dashboardSee who Anacor is hiring next, click here to view […]

7:32 am Anacor Pharma announces successful completion of End-of-Phase 2 meeting with FDA for the treatment of mild-to-moderate atopic dermatitis with AN2728

moreView todays social media effects on ANACView the latest stocks trending across Twitter. Click to view dashboardSee who Anacor is hiring next, click here to view […]

Anacor Pharmaceuticals Announces Successful Completion of End-of-Phase 2 Meeting With FDA for the Treatment of Mild-to-Moderate Atopic Dermatitis With AN2728

[at noodls] – PALO ALTO, Calif.–(BUSINESS WIRE)– Anacor Pharmaceuticals (NASDAQ:ANAC) announced today that it has successfully completed an End-of-Phase 2 meeting with the United States Food and Drug Administration … moreView todays social media effects on ANACView the latest stocks trending across Twitter. Click to view dashboardSee who Anacor is hiring next, click here to view […]

Anacor Pharmaceuticals to Present at the Cowen & Company 34th Annual Health Care Conference

[Business Wire] – Anacor Pharmaceuticals announced today that Geoff Parker, the company’s Chief Financial Officer, will provide a company overview at the Cowen & Company 34th Annual Health Care Conference on Monday, March 3, 2014 at 3:30 p.m. moreView todays social media effects on ANACView the latest stocks trending across Twitter. Click to view dashboardSee who Anacor is hiring next, […]

Anacor Pharmaceuticals Announces Publication of Article Describing Boron-Containing Compounds and Their Relevance to Dermatology

[Business Wire] – Anacor Pharmaceuticals announced today that a peer-reviewed article describing the recent progress of boron-based compounds in medicine and the properties of these compounds that support their development for the treatment of various sk moreView todays social media effects on ANACView the latest stocks trending across Twitter. Click to view dashboardSee who Anacor is hiring next, click here […]